EP Patent

EP3681473A1 — Topical formulations of chloroprocaine

Assigned to Sintetica SA · Expires 2020-07-22 · 6y expired

What this patent protects

Topical dosages and formulations of chloroprocaine, including gels and ointment, and methods of manufacturing and using same, are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy. The dosages and formulations are particularly u…

USPTO Abstract

Topical dosages and formulations of chloroprocaine, including gels and ointment, and methods of manufacturing and using same, are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy. The dosages and formulations are particularly useful during ophthalmic procedures or in response to ophthalmic abrasions or trauma based on their tolerability and pharmacokinetics.

Drugs covered by this patent

Patent Metadata

Patent number
EP3681473A1
Jurisdiction
EP
Classification
—
Expires
2020-07-22
Drug substance claim
No
Drug product claim
No
Assignee
Sintetica SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.